Healthcare AI funding is booming, but the money is flowing to fewer companies than ever before. As investors pour capital into a small group of breakout winners, founders are navigating a fundraising environment where expectations seem to change every quarter. Based on interviews with 24 healthcare founders and a dozen healthcare investors, Halle breaks down what is actually happening in the market today, from pitch meetings and diligence processes to the growing debate over whether AI has fundamentally changed venture capital itself.
Why healthcare AI fundraising has become a tale of two markets
The two questions dominating investor meetings in 2026
The metrics VCs are looking for today
The debate over whether investors should abandon traditional ownership targets
Why high valuations can be both a gift and a trap for founders
—
Show notes:
Submit questions for our Eric Larsen healthcare AI Q&A here
Podden och tillhörande omslagsbild på den här sidan tillhör
Massively Better Healthcare. Innehållet i podden är skapat av Massively Better Healthcare och inte av,
eller tillsammans med, Poddtoppen.